GLIVIN–M 2 Composition: GLIMEPIRIDE 2 MG + METFORMIN 500 MG SR (Sustained Release)

Overview: Glivin–M 2 is a bilayered tablet combining two key antidiabetic medications – Glimepiride and Metformin. This synergistic formulation is designed to provide effective blood sugar control in individuals with type 2 diabetes.

Key Components:

1. Glimepiride (2 mg): A sulfonylurea medication that stimulates the pancreas to produce insulin, helping lower blood sugar levels.
2. Metformin (500 mg SR): A biguanide that improves insulin sensitivity, reduces glucose production in the liver, and slows glucose absorption in the intestines. The sustained-release formulation ensures a gradual release over time.

Uses: Glivin–M 2 is prescribed for the following purposes:

1. Type 2 Diabetes Management: The combination of Glimepiride and Metformin targets different aspects of blood sugar regulation, providing comprehensive control in individuals with type 2 diabetes.
2. Improved Insulin Sensitivity: Metformin enhances the body’s response to insulin, making it more effective in lowering blood glucose levels.
3. Reduced Hepatic Glucose Production: Metformin suppresses glucose production in the liver, a common issue in diabetes.

How to Use:

• Take Glivin–M 2 exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a glass of water, typically with meals.
• Follow your healthcare provider’s instructions for dosage adjustments and frequency.
• Adhere to a healthy diet and exercise regimen as recommended by your healthcare provider.

Possible Side Effects: While Glivin–M 2 is generally well-tolerated, individuals may experience some side effects, including:

1. Hypoglycemia: Low blood sugar levels, particularly if meals are skipped or inadequate.
2. Gastrointestinal Distress: Common with Metformin, symptoms may include nausea, vomiting, or diarrhea.
3. Weight Gain: A potential side effect of sulfonylureas like Glimepiride.

It is important to report any persistent or severe side effects to your healthcare provider promptly.

Precautions:

• Inform your healthcare provider about your medical history, existing conditions, and current medications.
• Regularly monitor blood sugar levels as directed by your healthcare provider.
• Avoid excessive alcohol consumption, as it can enhance the risk of hypoglycemia.

Note: This information serves as a general guide. Consult your healthcare provider for personalized advice and to address specific concerns related to Glivin–M 2. Never self-prescribe or adjust your dosage without professional guidance